title: Follow-up of patients with mycosis fungoides after interferon α2b treatment failure.
abstract: BACKGROUND
  Treatment of T cell cutaneous lymphoma( CTCL) is a controversial subject and the effectiveness of treatment is still low.
  
  
  OBJECTIVE
  Report of single center experience of management CTCL after progression after first line treatment.
  
  
  METHODS
  We present 41 patients with CTCL, 29 received interferon α2b in first line, and 12 of them received second line therapy.
  
  
  RESULTS
  Overall response rate for second line therapy was 60%.
  
  
  CONCLUSIONS
  Results of the follow-up of patients with mycosis fungoides after interferon α2b treatment failure with the literature review and discussion.
authors.affiliation: Clinical Oncology Department, Oncology Center, Bydgoszcz, Poland. Head of the Department: Ewa Chmielowska MD, PhD.
authors.forename: Ewa
authors.initials: E
authors.lastname: Chmielowska
authors.affiliation: Clinic of Oncology and Brachytherapy, Nicolaus Copernicus University in Torun, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Poland. Head of the Department: Prof. Roman Makarewicz MD, PhD.
authors.forename: Maciej
authors.initials: M
authors.lastname: Studziński
authors.affiliation: Department of Bone Marrow Transplantation and Hematooncology, Nicolaus Copernicus University in Torun, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Poland. Head of the Department: Prof. Sebastian Giebel.
authors.forename: Sebastian
authors.initials: S
authors.lastname: Giebel
authors.affiliation: Clinical Oncology Department, Oncology Center, Bydgoszcz, Poland. Head of the Department: Ewa Chmielowska MD, PhD.
authors.forename: Anna
authors.initials: A
authors.lastname: Krause
authors.affiliation: Clinical Oncology Department, Oncology Center, Bydgoszcz, Poland. Head of the Department: Ewa Chmielowska MD, PhD.
authors.forename: Monika
authors.initials: M
authors.lastname: Olejniczak
authors.affiliation: Department of Dermatology, Univeristy Hosptal No. 1, Bydgoszcz, Poland. Head of the Department: Rafal Czajkowski MD, PhD.
authors.forename: Aleksandra
authors.initials: A
authors.lastname: Grzanka
keywords: chemotherapy; interferon; mycosis fungoides